Baxter Jumps After Q2 Beat, Boosted 2026 Guidance Reflects Turnaround Progress
Baxter raises annual profit forecast on strong demand for IV solutions
Baxter beats quarterly expectations on strong demand for medical devices
EU regulator warns of shortage in Baxter's cancer treatment until early 2027